openPR Logo
Press release

Gastrointestinal Therapeutics Market Research Report 2023 Growth, Recent Trends and Forecast to 2029 by Key Players | Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc

09-12-2023 08:57 AM CET | Health & Medicine

Press release from: Exactitude Consultancy

Exactitude Consultancy report 2023

Exactitude Consultancy report 2023

Gastrointestinal Therapeutics is a medical field that focuses on diagnosing, treating, and managing diseases affecting the gastrointestinal system. The increasing prevalence of gastrointestinal disorders like GRD, IBD, IBS, and peptic ulcers is driving demand for gastrointestinal therapeutics. Factors driving market expansion include the geriatric population, demand for efficient treatment alternatives, and the rise in ulcerative colitis and Crohn's disease.

"The global gastrointestinal therapeutics market is expected to grow at 8.6% CAGR from 2020 to 2029. It is expected to reach above USD 48.6 billion by 2029 from USD 20.4 billion in 2020."

Request for a free sample copy of this report-> https://exactitudeconsultancy.com/reports/2915/gastrointestinal-therapeutics-market/#request-a-sample

**Note - Updated Version 2023 is available

► What this report provides?

⇨ The research provides a comprehensive overview of the current state of the Gastrointestinal Therapeutics market and its anticipated future evolution.

⇨ Key companies manufacturing Gastrointestinal Therapeutics worldwide are profiled, providing an overview of their financials, product portfolio, recent developments, and future outlook.

⇨ The report evaluates the current opportunity and future growth potential of the Gastrointestinal Therapeutics market, providing estimates for its mid-to-long term evolution during the forecast period 2023-2029, aiming to identify potential trends and opportunities.

⇨ Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-over-year growth, competitive benchmarking, vendor identification, CMI quadrant, and other significant analysis, as well as development status.

⇨ Recent market trends and its potential for future growth

⇨ regional reports that can be customised upon request

► Who are the major players in this industry?

Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc., ALLERGAN, Takeda Pharmaceutical Company Limited, AstraZeneca, Astellas Pharma US, Inc., and Pfizer Inc, and others.

► Recent Developments in Gastrointestinal Therapeutics Market

Recent developments in Gastrointestinal Therapeutics industry, even after market report release, support market trends outlined in analysis.

In February 2021, Dr Reddy's Laboratories launched Lansoprazole delayed-release orally disintegrating tablets in the United States.

In February 2021, Dr Reddy's Laboratories launched Lansoprazole delayed-release orally disintegrating tablets in the United States.

In March 2020, Sebela Pharmaceuticals received approval from the United States Food and Drug Administration (FDA) for Pizensy (lactitol) in the treatment of chronic idiopathic constipation (CIC) in adults. Penny is an osmotic laxative that works by causing the influx of water into the small intestine leading to a laxative effect in the colon.

► What exactly does market segmentation cover?

Gastrointestinal Therapeutics Market by Type, 2020-2029, (USD Million)

» Prescription Based Gastrointestinal Therapeutics

» Otc Gastrointestinal Therapeutics

Gastrointestinal Therapeutics Market by Application, 2020-2029, (USD Million)

» Gastroenteritis

» Gi Bleeding

» Irritable Bowel Syndrome

» Peptic Ulcer Disease (Pud)

Gastrointestinal Therapeutics Market by Dosage Forms, 2020-2029, (USD Million)

» Oral

» Injections

Gastrointestinal Therapeutics Market by End User, 2020-2029, (USD Million)

» Hospitals

» Clinics

► Regional Analysis of the Gastrointestinal Therapeutics Market

The market development, current market trends, and some research methodologies are all covered in the Gastrointestinal Therapeutics Industry research report. It draws attention to crucial aspects like product portfolios, software architectures, and production strategies that have a direct impact on the market. Our research shows that even minor changes to a product's qualities can have a big impact on the previously mentioned criteria.

► Key Geographical Regions

North America (US, Canada)
Europe (Germany, UK, France, Italy, Spain)
Asia-Pacific (China, Australia, Japan)
Middle East and North Africa
Latin America       
        
► Table of Content:

1 Study Reporting
1.1 Gastrointestinal Therapeutics Product
1.2 Key Segments in This Study
1.3 Key Companies Covered
1.4 Market by Type
1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type
1.5 Market by Application

2 Executive Instantaneous
2.1 Global Gastrointestinal Therapeutics Market Size
2.1.1 Global Gastrointestinal Therapeutics Revenue
2.1.2 Global Gastrointestinal Therapeutics Production
2.2 Gastrointestinal Therapeutics Growth Rate (CAGR)
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio
2.3.2 Key Gastrointestinal Therapeutics Manufacturers
2.3.2.1 Gastrointestinal Therapeutics Manufacturing Base Distribution, Headquarters
2.3.2.2 Manufacturers Gastrointestinal Therapeutics Product Offered
2.3.2.3 Date of Manufacturers Enter into Gastrointestinal Therapeutics Market
2.4 Key Trends for Gastrointestinal Therapeutics Markets & Products

3 Market Size by Manufacturers
3.1 Gastrointestinal Therapeutics Production by Manufacturers
3.2 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Therapeutics Production by Regions

4.1 Global Gastrointestinal Therapeutics Production by Regions
4.1.1 Global Gastrointestinal Therapeutics Production Market Share by Regions
4.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Regions
4.2 United States
4.2.1 United States Gastrointestinal Therapeutics Production
4.2.2 United States Gastrointestinal Therapeutics Revenue
4.2.3 Key Players in United States
4.2.4 United States Gastrointestinal Therapeutics Import & Export
4.3 Europe
4.3.1 Europe Gastrointestinal Therapeutics Production
4.3.2 Europe Gastrointestinal Therapeutics Revenue

5 Gastrointestinal Therapeutics Consumption by Regions

5.1 Global Gastrointestinal Therapeutics Consumption by Regions
5.1.1 Consumption by Regions
5.1.2 Consumption Market Share by Regions
5.2 North America
5.2.1 North America Consumption by Application
5.2.2 North America Consumption by Countries
5.2.3 United States
5.2.4 Canada
5.2.5 Mexico
5.3 Europe
5.3.1 Europe Consumption by Application
5.3.2 Europe Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 UK
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific Consumption by Application
5.4.2 Asia Pacific Consumption by Countries
5.5.1 Central & South America) Consumption by Application
5.5.2 Central & South America Consumption by Country

6 Market Size by Type
6.1 Production by Type
6.2 Revenue by Type
6.3 Price by Type

7 Market Size by Application
7.1 Overview
7.2 Global Gastrointestinal Therapeutics Breakdown Dada by Application
7.2.1 Global Gastrointestinal Therapeutics Consumption by Application
7.2.2 Global Gastrointestinal Therapeutics Consumption Market Share by Application

8 Manufacturers Profiles
9 Production Forecasts
9.1 Gastrointestinal Therapeutics Production and Revenue Forecast
9.1.1 Global Gastrointestinal Therapeutics Production Forecast
9.1.2 Global Gastrointestinal Therapeutics Revenue Forecast
9.2 Gastrointestinal Therapeutics Production and Revenue Forecast by Regions
9.2.1 Global Gastrointestinal Therapeutics Revenue Forecast by Regions
9.2.2 Global Gastrointestinal Therapeutics Production Forecast by Regions
9.3 Gastrointestinal Therapeutics Key Producers Forecast
9.3.1 United States
9.3.2 Europe
9.3.3 China
9.3.4 Japan
9.4 Forecast by Type
9.4.1 Global Gastrointestinal Therapeutics Production Forecast by Type
9.4.2 Global Gastrointestinal Therapeutics Revenue Forecast by Type

10 Consumption Forecast
10.1 Gastrointestinal Therapeutics Consumption Forecast by Application
10.2 Gastrointestinal Therapeutics Consumption Forecast by Regions
10.3 North America Market Consumption Forecast
10.3.1 North America Gastrointestinal Therapeutics Consumption Forecast by Regions
10.3.2 United States
10.3.3 Canada
10.3.4 Mexico
10.4 Europe Market Consumption Forecast
10.4.1 Europe Gastrointestinal Therapeutics Consumption Forecast by Regions
10.4.2 Germany
10.4.3 France
10.4.4 UK
10.4.5 Italy
10.4.6 Russia
10.5 Asia Pacific Market Consumption Forecast
10.5.1 Asia Pacific Gastrointestinal Therapeutics Consumption Forecast by Regions
10.5.2 China
10.5.3 Japan
10.5.4 South Korea
10.5.5 India
10.5.6 Australia
10.5.7 Indonesia
10.5.8 Thailand
10.5.9 Malaysia
10.5.10 Philippines
10.5.11 Vietnam
10.6 Central & South America Market Consumption Forecast
10.6.1 Central & South America Gastrointestinal Therapeutics Consumption Forecast by Regions
10.6.2 Brazil
10.7 Middle East and Africa Market Consumption Forecast
10.7.1 Middle East and Africa Gastrointestinal Therapeutics Consumption Forecast by Regions
10.7.2 GCC Countries
10.7.3 Egypt
10.7.4 South Africa

11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Gastrointestinal Therapeutics Sales Channels
11.2.2 Gastrointestinal Therapeutics Distributors
11.3 Gastrointestinal Therapeutics Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Key Findings in the Global Gastrointestinal Therapeutics Study

14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer

Continue….

► Healthcare Trending Reports

https://www.openpr.com/news/3204352/fenugreek-market-is-expected-to-progress-to-reach-us-2-14

https://www.openpr.com/news/3204468/co2-incubators-market-status-growth-trends-and-outlook-2029

https://www.openpr.com/news/3204510/kidney-balloon-market-growth-accelerates-5-2-cagr-expected  

► Customization Service of the Report:

Exactitude Consultancy offers personalized reports tailored to your specific needs, with a sales team dedicated to ensuring you receive a report that meets your specific requirements.

► Research Methodology

The report is based on data analysis strategies by skilled data analysts. The research methodology involves collecting and analyzing information to provide significant market predictions. Interviews with market influencers make primary research relevant and practical. The secondary method provides a direct insight into demand and supply. Both primary and secondary data collection methods are used, along with publicly available sources like annual reports and white papers, to provide a comprehensive understanding of the market. The report offers precise data analysis and a comprehensive market tour.

Get a Sample Copy of the Gastrointestinal Therapeutics Market Research Report (Use Corporate mail id for quick response)-@ https://exactitudeconsultancy.com/reports/2915/gastrointestinal-therapeutics-market/#request-a-sample

► About Us

Exactitude Consultancy is a Market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our professional team works hard to fetch the most authentic research reports backed with impeccable data figures which guarantee outstanding results every time for you. So, whether it is the latest report from the researchers or a custom requirement, our team is here to help you in the best possible way.

► Connect Us:

PHONE NUMBER +1 (704) 266-3234

EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Therapeutics Market Research Report 2023 Growth, Recent Trends and Forecast to 2029 by Key Players | Abbott Laboratories, Johnson & Johnson, AbbVie Inc., Salix Pharmaceuticals, GlaxoSmithKline Plc here

News-ID: 3204547 • Views:

More Releases from Exactitude Consultancy

Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Huntington's Disease Market to Set Phenomenal Growth From 2025 to 2034
Introduction Huntington's Disease (HD) is a devastating rare, inherited neurodegenerative disorder that progressively impairs movement, cognition, and behavior. Affecting approximately 3 to 7 individuals per 100,000 globally, it continues to challenge patients, caregivers, and healthcare systems. Despite being rare, the growing investment in research, clinical trials, and novel treatment approaches is transforming the Huntington's Disease market into a promising frontier for biopharmaceutical innovation. The global Huntington's Disease market is poised for strong
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Hemophilia B Market Emerging Trends and Growth Prospects 2034
Introduction Hemophilia B is a rare, inherited bleeding disorder caused by a deficiency or dysfunction of clotting factor IX (FIX). Patients with Hemophilia B experience prolonged bleeding episodes, spontaneous internal hemorrhages, and joint damage, which can significantly impair quality of life. The disease predominantly affects males, with an estimated 1 in 25,000 male births worldwide. For decades, the mainstay of treatment has been factor IX replacement therapy, delivered intravenously. However, repeated infusions,
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billion by 2034
Lupus Nephritis Patient Pool Analysis Market is expected to reach USD 15.2 billi …
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE), an autoimmune disease where the immune system attacks the body's own tissues. LN affects the kidneys, causing inflammation that can lead to organ damage and, if left untreated, kidney failure. With SLE most commonly affecting women of childbearing age, lupus nephritis represents a significant clinical and socioeconomic burden worldwide. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71619 The
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity Ahead
Facioscapulohumeral Muscular Dystrophy (FSHD) Market Massive Growth opportunity …
Introduction Facioscapulohumeral muscular dystrophy (FSHD) is a rare genetic muscle disorder characterized by progressive weakness of facial, shoulder, and upper arm muscles, and eventually lower body muscles. It is the third most common type of muscular dystrophy, affecting approximately 1 in 8,000 to 1 in 20,000 individuals worldwide. FSHD is typically caused by abnormal expression of the DUX4 gene due to genetic mutations on chromosome 4. While there is currently no approved

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant